Company intelligence / Profile preview

TympaHealth

London, England, United Kingdomtympahealth.com ↗

Ownership: Private
Employees: ~51
Development stage: Other

Overview

The company has commercialized the world’s first all-in-one ear and hearing healthcare platform that enables high-resolution eardrum visualization, earwax removal via micro-suction, and hearing screening. It has performed over 150K patient evaluations/treatments to date. The system supports both private clinics and NHS settings in the UK as well as trials in the US following FDA registration. No clinical trial results are published; product performance validated through regulatory approvals (CE mark/FDA) and real-world adoption.

Therapeutic areas: NeurologyOther
Modalities: DeviceNon-pharmacological therapy (hearing assessment and treatment platform)
Industry: Digital Health Medical Devices

Partnerships

Boots Hearingcare (UK retail pharmacy chain partnership for nationwide coverage of service)NHS trusts/NHS England for community-based care pathways

Beyond the preview

Go deeper on TympaHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TympaHealth.

Explore the full profile